Thrombocytosis and STAT5 Activation in Chronic Myelogenous Leukemia Are Not Associated With JAK2 V617F or Calreticulin Mutations

被引：0
|
作者：
Turakhia, Samir [1 ]
Murugesan, Gurunathan [1 ]
Cotta, Claudiu [1 ]
Theil, Karl [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1519
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [1] Thrombocytosis and STAT5 Activation in Chronic Myelogenous Leukemia Are Not Associated With JAK2 V617F or Calreticulin Mutations
    Turakhia, Samir
    Murugesan, Gurunathan
    Cotta, Claudiu
    Theil, Karl
    MODERN PATHOLOGY, 2015, 28 : 382A - 382A
  • [2] Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations
    Turakhia, Samir K.
    Murugesan, Gurunathan
    Cotta, Claudiu V.
    Theil, Karl S.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (08) : 713 - 719
  • [3] STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant
    Funakoshi-Tago, Megumi
    Tago, Kenji
    Abe, Miyuki
    Sonoda, Yoshiko
    Kasahara, Tadashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) : 5296 - 5307
  • [4] Chronic Neutrophilic Leukemia with V617F JAK2 Mutation
    Gajendra, Smeeta
    Gupta, Ritu
    Chandgothia, Meenal
    Kumar, Lalit
    Gupta, Richa
    Chavan, Snehal Motilal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (02) : 139 - 142
  • [5] Chronic Neutrophilic Leukemia with V617F JAK2 Mutation
    Smeeta Gajendra
    Ritu Gupta
    Meenal Chandgothia
    Lalit Kumar
    Richa Gupta
    Snehal Motilal Chavan
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 139 - 142
  • [6] JAK-STAT PATHWAY IN MYELOPROLIFERATIVE NEOPLASMS: FROM JAK2 V617F TO CALRETICULIN MUTANTS
    Constantinescu, S. N.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 31 - 31
  • [7] Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
    Cordua, Sabrina
    Kjaer, Lasse
    Skov, Vibe
    Pallisgaard, Niels
    Hasselbalch, Hans C.
    Ellervik, Christina
    BLOOD, 2019, 134 (05) : 469 - 479
  • [8] JAK2 V617F mutation is absent in chronic lymphocytic leukemia
    Poulain, Stephanie
    Merchez, Maud
    Daudignon, Agnes
    Simon, Marc
    Duthilleul, Patrick
    Morel, Pierre
    LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2657 - 2658
  • [9] Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation
    Mc Lornan, Donald P.
    Percy, Melanie J.
    Jones, Amy V.
    Cross, Nicholas C. P.
    Mc Mullin, Mary Frances
    HAEMATOLOGICA, 2005, 90 (12) : 1696 - +
  • [10] The V617F JAK2 mutation inmyelodysplastic/myeloproliferative diseases is associated with marked thrombocytosis
    Billiet, J.
    Nollet, F.
    Van Droogenbroeck, J.
    Hidajat, M.
    Van Hoof, A.
    Criel, A.
    Selleslag, D.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 108 - 108
12345